Position
Marex Group plc in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$112.8K$579.45 → $491.53
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2022 | 10.1K | $5.65M | — | — | — | 0.8% |
| Q1 2024 | 122.5K | $71.2M | $581.21 | $246.2K | $65.3M | 2.3% |
| Q2 2024 | 120K | $66.4M | $553.00 | −$3.39M | −$1.44M | 1.8% |
| Q3 2024 | 120K | $74.2M | $618.57 | $7.87M | $4.95K | 1.7% |
| Q4 2024 | 120.9K | $62.9M | $520.23 | −$11.8M | $476.5K | 1.1% |
| Q1 2025 | 121.9K | $60.6M | $497.60 | −$2.74M | $454.8K | 1.2% |
| Q4 2025 | 1.28K | $743.4K | $579.45 | $105K | −$60M | 0.0% |
| Q1 2026 | 2.41K | $1.18M | $491.53 | −$112.8K | $553K | 0.0% |